CGMP/Finished Pharmaceuticals/Adulterated
Similar Posts
VITALITY may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use VITALITY, a product promoted and sold for sexual enhancement on https://www.zen-herbs.com and possibly in some retail stores.Check Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers
Prescription drugs should only be purchased from wholesale drug distributors licensed in the United States. Verify licensing through FDA database links.Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of-Specification Endotoxin Results in Certain Reserve Samples
FOR IMMEDIATE RELEASE – Nov. 6,2025 – LAKE ZURICH, Ill.— Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies is voluntarily recalling three lots (numbers 6133156, 6133194, 6133388) of Famotidine Injection, USP, 20 mgFDA In Brief: FDA seeks input on development and evaluation of abuse-deterrent formulations of central nervous system stimulants
FDA seeks input on development and evaluation of abuse-deterrent formulations of central nervous system stimulantsCOSMO KOREA – 11/03/2025
Unapproved New Drugs/Misbranded/BotoxFDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes
The U.S. Food and Drug Administration (FDA) is warning that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors.
